Sanderling is revolutionizing renal care in the United States, particularly in rural areas and for home dialysis patients. The company's mission is to provide high-quality dialysis and nephrology services to communities that traditionally lack access to these essential healthcare resources. Leveraging Advanced Telemedicine, Sanderling ensures that nephrology specialists are available to patients in rural communities, minimizing the need for extensive travel.
Founded in 2012 by Dr. Jerome Tannenbaum, a seasoned physician and developer/operator of over 250 small healthcare facilities, Sanderling has demonstrated unparalleled commitment to improving medical services across the nation. The company collaborates closely with local hospitals and physicians, leveraging advanced technology to bring cutting-edge renal care to even the most remote locations.
The recent Private Equity Round investment on 16 May 2022, led by Pharos Capital Group, has solidified Sanderling’s position in the industry. With a focus on transforming the healthcare landscape, Sanderling has attracted significant support from influential investors, signaling confidence in the company's innovative approach and long-term potential.